dr perlmutter parkinsons treatment glutathione Initial management of Parkinson's disease Perlmutter Receives $3.2M to Study
Perlmutter Receives $3.2M to Study Parkinson's Disease Brain Inflammation Mallinckrodt Institute of Radiology WashU Medicine Mechanism of Toxicity in Rotenone Models of Parkinson's Disease Journal of Neuroscience Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases Frontiers The Therapeutic Potential of Metformin in Neurodegenerative Diseases Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease Cellular and Molecular Neurobiology Springer Nature Link
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




